• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Donald L. Lamm, Brent A Blumenstein, +9 authors E. David Crawford
  • Medicine
  • The Journal of urology
  • 2000 (First Publication: 1 April 2000)
  • PURPOSE Bacillus Calmette-Guerin (BCG) immunotherapy has been widely accepted as the optimal treatment for carcinoma in situ and high grade superficial transitional cell carcinoma. However,Continue Reading
  • Robert C. Flanigan, S. E. Salmon, +6 authors E. David Crawford
  • Medicine
  • The New England journal of medicine
  • 2001 (First Publication: 6 December 2001)
  • BACKGROUND The value of nephrectomy in metastatic renal-cell cancer has long been debated. Several nonrandomized studies suggest a higher rate of response to systemic therapy and longer survival inContinue Reading
  • Bruce E. Hillner, James N. Ingle, +8 authors Susan Fisher Brown
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2003 (First Publication: 1 November 2003)
  • PURPOSE To update the 2000 ASCO guidelines on the role of bisphosphonates in women with breast cancer and address the subject of bone health in these women. RESULTS For patients with plainContinue Reading
  • Donna L. Berry, Brent A Blumenstein, +7 authors Ruth McCorkle
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2011 (First Publication: 10 March 2011)
  • PURPOSE Although patient-reported cancer symptoms and quality-of-life issues (SQLIs) have been promoted as essential to a comprehensive assessment, efficient and efficacious methods have not beenContinue Reading
  • Philip W. Kantoff, Thomas Joseph Schuetz, +11 authors Wayne R. Godfrey
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2010 (First Publication: 1 March 2010)
  • PURPOSE Therapeutic prostate-specific antigen (PSA) -targeted poxviral vaccines for prostate cancer have been well tolerated. PROSTVAC-VF treatment was evaluated for safety and for prolongation ofContinue Reading